4//SEC Filing
MANNINO RAPHAEL J 4
Accession 0001493152-20-000125
CIK 0001582554other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:06 PM ET
Size
18.3 KB
Accession
0001493152-20-000125
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Other
Common Stock, par value $0.0001 per share
2019-06-21+2,000→ 1,426,565 total - Award
Stock option (right to buy)
2020-01-01+100,000→ 100,000 totalExercise: $2.27Exp: 2030-01-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock.
- [F2]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001196697
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:06 PM ET
- Size
- 18.3 KB